Search results for: 'therapy manufacturing market; 2020- 2026'

23 Oct 2020  |  Global  |  Market Research

Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026

Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities

Infographics

×

The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...

The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...

02 Sep 2025  |  Global  |  Technology Research

Technological Advances in Engineered Cell Therapies, Global, 2025–2029

Emerging Trends and Technologies in Engineered Cell Therapies

Infographics

×

Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...

18 Oct 2024  |  Global  |  Market Research

Image-guided Therapy Market, Global, 2024-2029

Increased Demand for Minimally Invasive Procedures and the Surge in Day Surgeries at Outpatient Facilities are Driving Transformational Growth

Infographics

×

The image-guided therapy (IGT) market is growing rapidly, mainly driven by the rising preference for minimally invasive procedures, technological advancements in multimodal imaging, artificial intelligence, the use of software solutions that enable better clinical outcomes, and the high demand for precision medicine in oncology treatment. In additi...

As geopolitical tensions continue to disrupt critical supply chains and cloud global economic prospects, countries are increasingly working toward building robust multi-industry domestic manufacturing capabilities. While this trend is witnessed across many countries, emerging economies such as India, China, Indonesia, Vietnam, and Mexico are, parti...

This study examines the dynamic shift in the global manufacturing industry towards digitalization. Visible particularly in sectors such as automotive, aerospace, and electronics, the shift is characterized by the increasing adoption of automation, artificial intelligence (AI), the Internet of Things (IoT), and other such technologies. Supply chain ...

28 Nov 2024  |  Global  |  Technology Research

Top 10 Manufacturing Technologies Impacting the Automotive and Aerospace Industries

Additive Manufacturing and Robotics Technologies are the Key Enablers Transforming the Industry 4.0 Concept

Infographics

×

The automotive and aerospace manufacturing industries are rapidly advancing due to technological innovations and evolving market conditions. These groundbreaking manufacturing technologies hold the potential to solve complex problems and enhance efficiency and sustainability within these industries. However, increasing market changes, regulatory ...

The Middle East manufacturing sector is undergoing a structural transformation driven by decarbonization imperatives, energy transition, and the economic diversification agendas of the Gulf Cooperation Council (GCC) governments. Carbon intensity is emerging as a key competitive differentiator, particularly as the European Union (EU)'s Carbon Border...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...